Page 130 - 2019年9月第30卷第17期

药结核分枝杆菌的生长；氟喹诺酮类金属配合物具有低 [13] SASAKI H，HARAGUCHI Y，ITOTANI M，et al.Synthe-
浓度体外抗结核分枝杆菌活性，很可能对药敏性菌株或 sis and antituberculosis activity of a novel series of opti-
耐药菌株有效。目前抗结核分枝杆菌化合物的研究仅 cally active6-nitro-2，3-dihydroimidazo[2，1-b]oxazole[J].
停留在体外活性研究阶段，未来还需要更多的科研工作 J Med Chem，2006，49（26）：784-780.
[14] KRISHNARAO G，RAJU M，NARAYANASWAMY VK，
者参与其体内活性的研究，为抗结核的新药研发奠定
et al. Synthesis，antibacterial activity of 2，4-disubstituted
基础。
oxazoles and thiazoles as bioisosteres[J]. Lett Drug Des
参考文献
Disc，2009，6（1）：21-28.
[ 1 ] WORLD HEALTH ORGANIZATION. Global tuberculo-
[15] KUANG R，SHUE H J，BLYTHIN D J，et al. Discovery of
sis report 2018[EB/OL].[2019-06-09].http：//www.who.
a highly potent series of oxazole-based phosphodiesterase
int/tb/publications/global_report/en/.
4 inhibitors[J]. Bioorg Med Chemistry Lett，2007，17（18）：
[ 2 ] CHOBY BA，HUNTER P. Respiratory infections：Pulmo-
5150-5154.
nary tuberculosis[J]. Fp Essent，2015，429（2）：22-29.
[16] SEMENYUTA I，KOVALISHYN V，TANCHUK V，et al.
[ 3 ] SHI R，ITAGAKI N，SUGAWARA I.Overview of anti-tu-
1，3-Oxazole derivatives as potential anticancer agents：
berculosis（TB）drugs and thei resistance mechanisms[J].
computer modeling and experimental study[J]. Comput Bi-
Mini Rev Me Chem，2007，7（11）：1177-1185. ol Chem，2016，65（11）：8-15.
[ 4 ] O’BRIEN RJ，NUNN PP. The need for new drugs against [17] ELMEGEED GA，BAIUOMY AR，ABDELHALIM MM，
tuberculosis. Obstacles，opportunities，and next steps[J]. et al. Synthesis and antidepressant evaluation of five nov-
Am J Respir Crit Care Med，2001，162（5）：1055-1058.
el heterocyclic tryptophan-hybrid derivatives[J]. Arch
[ 5 ] TAMARU A，NAKAJIMA C，WADA T，et al. Dominant
Pharm，2010，343（5）：261-267.
incidence of multidrug and extensively drug-resistant spe- [18] ESWARAN S，ADHIKARI AV，KUMAR RA. New 1，3-
cific mycobacterium tuberculosis clones in osaka prefec- oxazolo[4，5-c]quinoline derivatives：synthesis and evalua-
ture[J]. PLoS One，2012，7（8）：728-735. tion of antibacterial and antituberculosis properties[J]. Eur
[ 6 ] LI X，WANG H，JING H，et al. Population-based surveil- J Med Chem，2010，45（3）：957-966.
lance of extensively drug-resistanttuberculosis in shan- [19] MAO J，WAN B，WANG Y. Chemical hybridization，and
dong province[J]. Int J Tuberc Lung Dis，2012，16（5）： drug design identify a chemically unique antituberculosis
612-614. agent-coupling serendipity and rational approaches to
[ 7 ] KERI RS，PATIL SA. Quinoline：a promising antitubercu- drug discovery[J]. Chem Med Chem，2007，2（6）：811-
lar target[J]. Biomed Pharmacother，2014，68（8）：1161- 813.
1175. [20] MAO J，YUAN H，WANG Y，et al. Synthesis and antitu-
[ 8 ] 许红霞，杨少辉，邢建辉.新型抗结核药及其候选药物的 berculosis activity of novel mefloquine-isoxazole carbox-
研究进展[J].中国药房，2015，26（4）：553-557. ylic esters as prodrugs[J]. Bioorg Med Chem Lett，2010，20
[ 9 ] PREISS L，LANGER JD，OZKAN Y，et al. Structure of （3）：1263-1268.
the mycobacterial ATP synthase Fo rotor ring in complex [21] ESWARN S，AIRODY VA，NISHITH K，et al. Design and
with the anti-TB drug bedaquiline[J]. Sci Adv，2015，1（4）： synthesis of some newquinoline-3-carbohydrazole deriva-
17-25. tives as potential antimycobacterial agents[J]. Bioorg Med
[10] CHAHINE EB，KAROUI LR，MANSOUR H. Bedaqui- Chem Lett，2011，20（4）：1040-1044.
line：a novel diarylquinoline for multidrug-resistant tuber- [22] LUN S，GUO H，ONAJOLE O K，et al. Indoleamides are
culosis[J]. Ann Pharmacother，2014，48（1）：107-115. active against drug-resistant mycobacterium tuberculosis
[11] WANG D，ZHU X，CUI C，et al. Discovery of novel aceto- [J]. Nat Commun，2013，14（4）：2907-2913.
hydroxyacid synthase inhibitors as active agents against [23] RAVINDER RK，JAN J，SRINIVASA PS，et al. Design，
mycobacterium tuberculosis by virtual screening and bio- synthesis，and biological evaluation of indole-2-carbox-
assay[J]. J Chem Inf Model，2013，53（2）：343-353. amides：a promising class of antituberculosis agents[J]. J
[12] LU W，BAIG IA，SUN HJ，et al. Synthesis，crystal struc- Med Chem，2013，56（21）：8849-8859.
ture and biological evaluation of substituted quinazoli- [24] TREFZER C，RENGIFOGONZALEZ M，HINNER MJ，
none benzoates as novel antituberculosis agents targeting et al. Benzothiazinones：prodrugs that covalently modify
acetohydroxyacid synthase[J]. Eur J Med Chem，2015，94 the decaprenylphosphoryl-β-D-ribose 2’-epimerase DprE1
（7）：298-305. of mycobacterium tuberculosis[J]. J Ame Chem Soc，2010，

中国药房 2019年第30卷第17期 China Pharmacy 2019 Vol. 30 No. 17 ·2429 ·